Preprint Research Accelerated COVID Treatment Response
During the early phase of the pandemic, approximately 40% of the COVID-19 literature was shared as preprints – freely available manuscripts that are shared prior to peer-review.
Category: Other Infections
Other Infections
Latest
Other Infections
Latest
CDC to Provide $300M for Community HCW COVID-19 Vaccine Programs
The CDC will provide $300 million to jurisdictions for community health worker (CHW) services to support COVID-19 prevention and control, and an additional $32 million for training, technical assistance, and evaluation.
Other Infections
Latest
Correlations Between COVID-19 Severity in Lungs, Related Neurological Conditions
CT lung imaging and MRI brain scans have detected a visual correlation between COVID-19 disease...
How Did the Rise of Telemedicine Change Airway Clearance Therapy for Cystic Fibrosis Patients?
For patients with cystic fibrosis, airway clearance physical therapy appointments have moved online and at-home lung function testing has become commonplace during the COVID-19 pandemic.
Read More
Managing ARDS Risk in Pregnant Women
Coronavirus infections may be more frequent in pregnant women than in the general population, and those who contract the virus could also be more susceptible to acute respiratory distress syndrome.
Read More
Smoking and COVID-19 Risk
A new paper published online in the Annals of the American Thoracic Society discusses how smoking may affect risk for COVID-19 and the types of research that are needed to better understand the link between smoking and COVID-19 risk.
Read More
COVID-19 Cases in Nursing Homes Plummeting
Recent CMS data shows that nursing homes have seen an 82% decline in new COVID cases among residents since the peak in mid-December 2020.
Read More
COVID-19 Vaccination Rate by State: March 3
Over 52 million Americans (15.7% of the US population) have received at least one COVID-19 vaccine dose, and 8.1% have been fully-immunized with their second dose.
Read More
Monoclonal Antibodies Effective against MERS Coronavirus in First Human Trial
The first Phase 1 clinical trial of two monoclonal antibodies to treat Middle East respiratory syndrome coronavirus (MERS-CoV) found that they were well tolerated and generally safe when administered simultaneously to healthy adults.
Read More
Biden: Enough Vaccine Doses for All US Adults by May 31
President Biden pledged Tuesday that the United States will have enough COVID-19 vaccine doses for every adult in America by the end of May, moving up his administration’s previous timeline by two months.
Read More
CFF Grant to Advance Nitric Oxide Therapy for NTM Pulmonary Disease
Over $2 million in CFF funding will support research into high concentration inhaled nitric oxide for the treatment of Nontuberculous Mycobacteria Pulmonary Disease (NTM).
Read More
FDA Authorizes J&J COVID-19 Vaccine
On Saturday, the US FDA issued an emergency use authorization (EUA) for the Janssen COVID-19 Vaccine from Johnson & Johnson. It is the third vaccine authorized in the United States for the prevention of COVID-19 in patients 18-and-older caused by SARS-CoV-2.
Read More
New York Coronavirus Variant Gaining Foothold in City
A novel variant of COVID-19 called B.1.526 has been detected in New York City and may now account for one-in-four cases in the region.
Read More
California COVID-19 Variant Now in 19 States, Seven Countries
CAL.20C, a California variant of COVID-19, now accounts for nearly half of current cases in Southern California and is quickly spreading around the United States.
Read More
Low Reinfection Risk for People with SARS-CoV-2 Antibodies
People who have had evidence of a prior infection with SARS-CoV-2 appear to be well protected against being reinfected with the virus, at least for a few months.
Read More